Polyoxyl 20 Cetostearyl Ether
Based on 1 Customer Validation
Polyoxyl 20 Cetostearyl Ether can be used as an excipient, such as Emulsifier and solubilizer for emulsions and creams, etc. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs.
For research use only. We do not sell to patients.
- CAS No.: 68439-49-6
-
Storage:
Store at room temperature, keep dry and cool.
In solvent -80°C, 1 year , -20°C, 6 months
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-W012723
2-Hydroxyethyl methacrylateHydroxyester Compound -
HY-W011103
Diheptyl phthalateBiochemical Assay Reagent -
HY-W250166
Polyoxyethylene tridecyl etherBiochemical Assay Reagent -
HY-W105310A
Croconic acid disodiumlysine crotonylation Modulator -
HY-W110551
2-Methacryloyloxyethyl phosphorylcholinePolymer Monomer -
HY-B0966
DioxybenzoneUV Blocker -
HY-W110584
Carboxybetaine methacrylateAmphoteric Ionic Compound -
HY-W013538
1,2-Bis(maleimido)ethaneProtein Cross-Linking Agent -
HY-W089777
3-GlycidyloxypropyltrimethoxysilaneBiochemical Assay Reagent -
HY-W105423
Methacrylic acid N-hydroxysuccinimide esterPolymer -
HY-121254
GERI-BP002-AACAT Inhibitor
Biological Activity
Description
Chemical Information
-
CAS No. 68439-49-6
-
Appearance Solid
-
Color White to off-white
-
SMILES
[Polyoxyl 20 Cetostearyl Ether]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Store at room temperature, keep dry and cool
In solvent -80°C 1 year -20°C 6 months
Protocols
-
Protocol for Pharmacokinetic Study
Pharmacokinetic studies quantify how an organism handles a drug over time through absorption, distribution, metabolism, and excretion, and the core experimental readout is the concentration-time profile of parent drug and, when relevant, metabolites in biological matrices such as plasma, whole blood, urine, bile, or tissue. Pharmacokinetic analysis links dose, route, exposure, clearance, half-life, distribution, bioavailability, and systemic exposure to drug efficacy and toxicity hypotheses rather than measuring a signaling pathway directly. The literature links pharmacokinetics to drug-development phenotypes by showing that drug metabolism and pharmacokinetics influence compound progression, exposure-response interpretation, safety margins, dosing strategy, and failure risk during discovery and development. DMPK science contributes to compound optimization by integrating physicochemical properties, in vitro metabolism, transporter behavior, in vivo exposure, and pharmacodynamic contex
Purity & Documentation
-
Data Sheet (263 KB)
-
SDS (758 KB)
- English - EN (758 KB)
- Français - FR (758 KB)
- Deutsch - DE (758 KB)
- Norwegian - NO (758 KB)
- Español - ES (758 KB)
- Swedish - SV (758 KB)
- Italian - IT (758 KB)
- Korean - KR (758 KB)
- Portuguese - PT (758 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Polyoxyl 20 Cetostearyl Ether Related Classifications
HY-154639 Related Classifications
Powered by Bioz